Kiani et al., 2011 - Google Patents
Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosusKiani et al., 2011
View HTML- Document ID
- 16997836179178550801
- Author
- Kiani A
- Post W
- Magder L
- Petri M
- Publication year
- Publication venue
- Rheumatology
External Links
Snippet
Objectives. Cardiovascular disease remains the major cause of death in SLE. We assessed the degree to which cardiovascular risk factors (CVRFs) and disease activity were associated with 2-year changes in measures of subclinical atherosclerosis. Methods. One …
- 206010003210 Arteriosclerosis 0 title abstract description 65
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
- G06Q50/24—Patient record management
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/328—Health insurance management, e.g. payments or protection against fraud
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/345—Medical expert systems, neural networks or other automated diagnosis
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
- G06F19/322—Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/3431—Calculating a health index for the patient, e.g. for risk assessment
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kiani et al. | Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus | |
Tillett et al. | Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort | |
Ten Kate et al. | Increased aortic valve calcification in familial hypercholesterolemia: prevalence, extent, and associated risk factors | |
Magder et al. | Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus | |
van Herk-Sukel et al. | Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis | |
Diederichsen et al. | Discrepancy between coronary artery calcium score and HeartScore in middle-aged Danes: the DanRisk study | |
Kiani et al. | Coronary calcification in SLE: comparison with the Multi-Ethnic Study of Atherosclerosis | |
Cacoub et al. | Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the REduction of Atherothrombosis for Continued Health (REACH) Registry Europe | |
Eder et al. | Atherosclerosis in psoriatic disease: latest evidence and clinical implications | |
Pen et al. | Discordance between Framingham Risk Score and atherosclerotic plaque burden | |
Mangiapane et al. | Prescription prevalence and continuing medication use for secondary prevention after myocardial infarction: the reality of care revealed by claims data analysis | |
Im et al. | Inflammatory burden interacts with conventional cardiovascular risk factors for carotid plaque formation in rheumatoid arthritis | |
Wemmelund et al. | Low-dose aspirin and rupture of abdominal aortic aneurysm | |
Fagerli et al. | Selecting patients with ankylosing spondylitis for TNF inhibitor therapy: comparison of ASDAS and BASDAI eligibility criteria | |
Paixao et al. | Coronary artery calcification and family history of myocardial infarction in the Dallas heart study | |
Villa et al. | Prediction of cardiovascular risk in patients with familial hypercholesterolaemia | |
Ozen et al. | The 2013 ACC/AHA 10-year atherosclerotic cardiovascular disease risk index is better than SCORE and QRisk II in rheumatoid arthritis: is it enough? | |
Kravvariti et al. | Progression of subclinical atherosclerosis in systemic lupus erythematosus versus rheumatoid arthritis: the impact of low disease activity | |
Vagnarelli et al. | Troponin T elevation in acute aortic syndromes: Frequency and impact on diagnostic delay and misdiagnosis | |
Briot et al. | Bone loss in patients with early inflammatory back pain suggestive of spondyloarthritis: results from the prospective DESIR cohort | |
Ijäs et al. | Pre-pregnancy overweight overtakes gestational diabetes as a risk factor for subsequent metabolic syndrome | |
Fenech et al. | Poor awareness of hypertension in France: the CONSTANCES population-based study | |
Jacobs et al. | Monitoring of rheumatoid arthritis disease activity in individual patients: still a hurdle when implementing the treat-to-target principle in daily clinical practice | |
Jeebun et al. | Are clinical parameters and biomarkers predictive of severity of acute pulmonary emboli on CTPA? | |
Li et al. | Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study |